Fusion Pharmaceuticals Inc (DELISTED) (FUSN:DL)
21.55
0.00 (0.00%)
USD |
NASDAQ |
Jun 04, 16:00
Fusion Pharmaceuticals Enterprise Value: 1.672B for June 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 04, 2024 | 1.672B |
| June 03, 2024 | 1.672B |
| May 31, 2024 | 1.670B |
| May 30, 2024 | 1.665B |
| May 29, 2024 | 1.660B |
| May 28, 2024 | 1.664B |
| May 24, 2024 | 1.666B |
| May 23, 2024 | 1.668B |
| May 22, 2024 | 1.670B |
| May 21, 2024 | 1.667B |
| May 20, 2024 | 1.671B |
| May 17, 2024 | 1.669B |
| May 16, 2024 | 1.665B |
| May 15, 2024 | 1.671B |
| May 14, 2024 | 1.662B |
| May 13, 2024 | 1.662B |
| May 10, 2024 | 1.666B |
| May 09, 2024 | 1.658B |
| May 08, 2024 | 1.659B |
| May 07, 2024 | 1.659B |
| May 06, 2024 | 1.661B |
| May 03, 2024 | 1.664B |
| May 02, 2024 | 1.667B |
| May 01, 2024 | 1.661B |
| April 30, 2024 | 1.662B |
| Date | Value |
|---|---|
| April 29, 2024 | 1.659B |
| April 26, 2024 | 1.657B |
| April 25, 2024 | 1.655B |
| April 24, 2024 | 1.655B |
| April 23, 2024 | 1.657B |
| April 22, 2024 | 1.648B |
| April 19, 2024 | 1.643B |
| April 18, 2024 | 1.643B |
| April 17, 2024 | 1.642B |
| April 16, 2024 | 1.643B |
| April 15, 2024 | 1.645B |
| April 12, 2024 | 1.648B |
| April 11, 2024 | 1.652B |
| April 10, 2024 | 1.652B |
| April 09, 2024 | 1.654B |
| April 08, 2024 | 1.655B |
| April 05, 2024 | 1.648B |
| April 04, 2024 | 1.658B |
| April 03, 2024 | 1.650B |
| April 02, 2024 | 1.646B |
| April 01, 2024 | 1.643B |
| March 28, 2024 | 1.607B |
| March 27, 2024 | 1.605B |
| March 26, 2024 | 1.605B |
| March 25, 2024 | 1.595B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-102.01M
Minimum
Aug 11 2022
1.672B
Maximum
Jun 03 2024
224.88M
Average
133.74M
Median
Jun 23 2023
Enterprise Value Benchmarks
| AstraZeneca PLC | 264.05B |
| Landos Biopharma Inc (DELISTED) | 42.67M |
| Acasti Pharma Inc | 3.783M |
| Aurinia Pharmaceuticals Inc | 426.11M |
| Edesa Biotech Inc | 10.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.67M |
| Total Expenses (Quarterly) | 35.86M |
| EPS Diluted (Quarterly) | -0.40 |
| Earnings Yield | -6.59% |
| Normalized Earnings Yield | -7.564 |